Editor's Choice: Best of JAMA 2022
N. D. Beaulieu, PhD; M. E. Chernew, PhD; J. M. McWilliams, MD, PhD; et al
Editorial: Health Systems—The Present and the Future
L. P. Casalino, MD, PhD
January 24, 2023
Explore the latest in medicine including coronavirus (COVID-19) science, blood pressure guidelines, sepsis definitions, autism and cancer science, and more.
Home | New Online
Explore the latest research in hypertension, diabetes, stroke, dementia, machine learning, and more all completely free and open access.
Explore the latest advances in PCI and device therapy, treatment of myocardial infarction, dyslipidemia, heart failure, afib & rhythm disorders, TAVR, and more.
Explore the latest treatments for vitiligo, hidradenitis suppurativa, lichen sclerosus, melanoma, cosmetic dermatology, and more.
Explore the latest in national and global health policy, including health care pricing, delivery, access, quality, safety, equity, and reform.
Explore the latest in medicine including high-value care, levothyroxine timing, gabapentin for alcohol withdrawal, and more.
Explore the latest in brain science including dementia, traumatic brain injury, cerebellar stroke, restless arms, herpes pain, and more.
Explore the latest in cancer science including checkpoint inhibitors, DCIS, breast prostate and lung cancer treatment, aspirin prevention, biomarkers, and more.
Explore the latest in vision science including causes & treatment of cataract, glaucoma, retinal disorders, and more.
Explore the latest in management of tonsillitis, nystagmus, fistulae, and other head and neck disorders.
Explore the latest in child health including food and nutrition, Kawasaki disease and C difficile, effects of media, and more.
Explore the latest science of anxiety, autism, depression, OCD, psychosis, psychotherapy, schizophrenia, and more.
Explore the latest techniques in bariatric surgery, enterocutaneous fistula and hernia repair, minimally invasive surgery, and more.
A description of changes in the role and authority of the FDA and in the number of drugs the FDA has approved from 1983 to 2018.
This systematic analysis describes cancer burden for 29 cancer groups across 204 countries from 2010 through 2019 to provide data needed for cancer control planning.
This cohort study reports the trends and variations in skin and subcutaneous diseases, along with malignant melanoma and keratinocyte carcinoma, in the 50 states and the District of Columbia for the past 3 decades.
This guideline updates recommendations for use of intermittent inhaled corticosteroids (ICSs), add-on long-acting muscarinic antagonists (LAMAs), fractional exhaled nitric oxide measures, indoor allergen mitigation, immunotherapy, and bronchial thermoplasty for management of adolescents and adults with asthma.
Practices that promote clinician presence and connection during patient visits: preparation and listening with intent, agreeing on what matters most, connecting with the patient’s story, and exploring...
This Global Burden of Disease study estimates changes in prevalence of major neurological disorders in the US by age and sex between 1990 and 2017.
In this guideline, the USPSTF recommends screening for colorectal cancer in all adults aged 50 to 75 years (A recommendation). The USPSTF recommends screening for colorectal cancer in adults aged 45 to 49 years (B recommendation). The USPSTF recommends that clinicians selectively offer screening for colorectal cancer in adults aged 76 to 85 years (C recommendation).
In this guideline, the USPSTF recommends screening for hypertension in adults 18 years or older with office blood pressure measurement, and obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment (A recommendation).
In this guideline, the USPSTF recommends annual screening for lung cancer with low-dose CT in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years (B recommendation)
In this guideline, the USPSTF recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 years who have overweight or obesity (B recommendation).
This consensus guideline recommends items to include in reports of randomized trials modified post-protocol under extenuating circumstances, to improve the transparency, quality, and interpretability of trial reporting.
Explore the latest patient information from JAMA Network, including easy-to-understand information about prevention and management of common illnesses
Editors' summaries, author interviews, and more from podcasts across 13 JAMA Network journals. Listen and subscribe now.
The latest news from JAMA Network on trending topics in clinical medicine.
A collection of articles and resources on the epidemiology, diagnosis, and management of high blood pressure.
Home | JNC8 Guidelines
A gallery of fine art representations of mental health and illness
Read The Third International Consensus Definitions for Sepsis and Septic Shock
Guideline | Collection
A collection of resources about advances in artificial intelligence in health care and medicine.
An online resource to help clinicians and the public understand the latest in precision medicine
Articles addressing health and humanitarian effects of war, management of violence-related injuries and trauma, and health care needs of refugees and displaced people.
The Nuremberg Code, Declaration of Helsinki, and Declaration of Geneva provide a set of ethical principles regarding human experimentation and clinical care
Declaration | Collection
Clinically themed interactive crossword puzzles from JAMA created by New York Times crossword authors.
A collection of JAMA Network articles published to coincide with specialty society conferences.
A unique one-year fellowship opportunity offered by JAMA to introduce physicians to all facets of editing and publishing a major medical journal
Helping you achieve your advertising and recruitment goals. Explore our consultative and strategic media options today